Skip to main content

Published locations for Dasatinib adds no survival benefit to docetaxel in mCRPC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dasatinib adds no survival benefit to docetaxel in mCRPC

User login

  • Reset your password
  • /content/dasatinib-adds-no-survival-benefit-docetaxel-mcrpc
  • /oncologypractice/article/57954/genitourinary-cancer/dasatinib-adds-no-survival-benefit-docetaxel
  • /hematology-oncology/article/57954/genitourinary-cancer/dasatinib-adds-no-survival-benefit-docetaxel